Phagos focuses on addressing antimicrobial resistance through the development of bacteriophage-based treatments. The company offers customizable drugs that use the evolutionary potential of bacteriophages to target and eliminate resistant bacteria. It primarily serves the healthcare sector, providing solutions to combat life-threatening infectious diseases.